+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Structure of human ceramide synthase 6 (CerS6) bound to C16:0 | |||||||||
![]() | Final cryoSPARC sharpened map after NU refinement used for model refinement | |||||||||
![]() |
| |||||||||
![]() | CERAMIDE / SPHINGOLIPID / COVALENT INTERMEDIATE / MEMBRANE PROTEIN | |||||||||
Function / homology | ![]() sphingoid base N-palmitoyltransferase / sphingosine N-acyltransferase activity / sphingolipid biosynthetic process / Sphingolipid de novo biosynthesis / ceramide biosynthetic process / inflammatory response / endoplasmic reticulum membrane / DNA binding / membrane Similarity search - Function | |||||||||
Biological species | ![]() ![]() ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.2 Å | |||||||||
![]() | Pascoa TC / Pike ACW / Chi G / Stefanic S / Quigley A / Chalk R / Mukhopadhyay SMM / Venkaya S / Dix C / Moreira T ...Pascoa TC / Pike ACW / Chi G / Stefanic S / Quigley A / Chalk R / Mukhopadhyay SMM / Venkaya S / Dix C / Moreira T / Tessitore A / Cole V / Chu A / Elkins JM / Pautsch A / Schnapp G / Carpenter EP / Sauer DB | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: Structural basis of the mechanism and inhibition of a human ceramide synthase. Authors: Tomas C Pascoa / Ashley C W Pike / Christofer S Tautermann / Gamma Chi / Michael Traub / Andrew Quigley / Rod Chalk / Saša Štefanić / Sven Thamm / Alexander Pautsch / Elisabeth P ...Authors: Tomas C Pascoa / Ashley C W Pike / Christofer S Tautermann / Gamma Chi / Michael Traub / Andrew Quigley / Rod Chalk / Saša Štefanić / Sven Thamm / Alexander Pautsch / Elisabeth P Carpenter / Gisela Schnapp / David B Sauer / ![]() ![]() ![]() Abstract: Ceramides are bioactive sphingolipids crucial for regulating cellular metabolism. Ceramides and dihydroceramides are synthesized by six ceramide synthase (CerS) enzymes, each with specificity for ...Ceramides are bioactive sphingolipids crucial for regulating cellular metabolism. Ceramides and dihydroceramides are synthesized by six ceramide synthase (CerS) enzymes, each with specificity for different acyl-CoA substrates. Ceramide with a 16-carbon acyl chain (C16 ceramide) has been implicated in obesity, insulin resistance and liver disease and the C16 ceramide-synthesizing CerS6 is regarded as an attractive drug target for obesity-associated disease. Despite their importance, the molecular mechanism underlying ceramide synthesis by CerS enzymes remains poorly understood. Here we report cryo-electron microscopy structures of human CerS6, capturing covalent intermediate and product-bound states. These structures, along with biochemical characterization, reveal that CerS catalysis proceeds through a ping-pong reaction mechanism involving a covalent acyl-enzyme intermediate. Notably, the product-bound structure was obtained upon reaction with the mycotoxin fumonisin B1, yielding insights into its inhibition of CerS. These results provide a framework for understanding CerS function, selectivity and inhibition and open routes for future drug discovery. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 70.7 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 26.3 KB 26.3 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 8.9 KB | Display | ![]() |
Images | ![]() | 134.2 KB | ||
Masks | ![]() | 75.1 MB | ![]() | |
Filedesc metadata | ![]() | 7.5 KB | ||
Others | ![]() ![]() ![]() | 37 MB 69.5 MB 69.5 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 8qz6MC ![]() 8qz7C ![]() 9eotC M: atomic model generated by this map C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Final cryoSPARC sharpened map after NU refinement used for model refinement | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.87467 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Mask #1
File | ![]() | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: Final cryoSPARC unsharpened map
File | emd_18770_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Final cryoSPARC unsharpened map | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: halfmap1
File | emd_18770_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | halfmap1 | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: halfmap2
File | emd_18770_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | halfmap2 | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : CerS6-Nb22 complex
Entire | Name: CerS6-Nb22 complex |
---|---|
Components |
|
-Supramolecule #1: CerS6-Nb22 complex
Supramolecule | Name: CerS6-Nb22 complex / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#2 |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 114.8 KDa |
-Macromolecule #1: Isoform 2 of Ceramide synthase 6
Macromolecule | Name: Isoform 2 of Ceramide synthase 6 / type: protein_or_peptide / ID: 1 / Number of copies: 2 / Enantiomer: LEVO / EC number: sphingoid base N-palmitoyltransferase |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 42.418348 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: MAGILAWFWN ERFWLPHNVT WADLKNTEEA TFPQAEDLYL AFPLAFCIFM VRLIFERFVA KPCAIALNIQ ANGPQIAPPN AILEKVFTA ITKHPDEKRL EGLSKQLDWD VRSIQRWFRQ RRNQEKPSTL TRFCESMWRF SFYLYVFTYG VRFLKKTPWL W NTRHCWYN ...String: MAGILAWFWN ERFWLPHNVT WADLKNTEEA TFPQAEDLYL AFPLAFCIFM VRLIFERFVA KPCAIALNIQ ANGPQIAPPN AILEKVFTA ITKHPDEKRL EGLSKQLDWD VRSIQRWFRQ RRNQEKPSTL TRFCESMWRF SFYLYVFTYG VRFLKKTPWL W NTRHCWYN YPYQPLTTDL HYYYILELSF YWSLMFSQFT DIKRKDFGIM FLHHLVSIFL ITFSYVNNMA RVGTLVLCLH DS ADALLEA AKMANYAKFQ KMCDLLFVMF AVVFITTRLG IFPLWVLNTT LFESWEIVGP YPSWWVFNLL LLLVQGLNCF WSY LIVKIA CKAVSRGKAG KWNPLHVSKD DRSDAENLYF Q UniProtKB: Ceramide synthase 6 |
-Macromolecule #2: Nanobody-22
Macromolecule | Name: Nanobody-22 / type: protein_or_peptide / ID: 2 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() ![]() |
Molecular weight | Theoretical: 15.070657 KDa |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: QVQLVESGGG LVQAEGSLRL SCAASGRTFR TYGMGWFRQA PGKEREFVAA LNWSGSSTYY ADSVKGRFTI SRDNAKNTAY LQMNSLKPE DTAVYYCAAL RRKAEYGSRS IADFDSWSKG TPVTVSSHHH HHHEPEA |
-Macromolecule #3: PALMITIC ACID
Macromolecule | Name: PALMITIC ACID / type: ligand / ID: 3 / Number of copies: 2 / Formula: PLM |
---|---|
Molecular weight | Theoretical: 256.424 Da |
Chemical component information | ![]() ChemComp-PLM: |
-Macromolecule #4: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE
Macromolecule | Name: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE / type: ligand / ID: 4 / Number of copies: 2 / Formula: PC1 |
---|---|
Molecular weight | Theoretical: 790.145 Da |
Chemical component information | ![]() ChemComp-PC1: |
-Macromolecule #5: 2-acetamido-2-deoxy-beta-D-glucopyranose
Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 5 / Number of copies: 2 / Formula: NAG |
---|---|
Molecular weight | Theoretical: 221.208 Da |
Chemical component information | ![]() ChemComp-NAG: |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 5 mg/mL | ||||||||
---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 7.5 Component:
Details: 20 mM HEPES pH 7.5, 200 mM NaCl, and 0.01 % (w/v) GDN | ||||||||
Grid | Model: Quantifoil R1.2/1.3 / Material: GOLD / Mesh: 200 / Support film - Material: CARBON / Support film - topology: HOLEY / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 60 sec. / Pretreatment - Atmosphere: AIR | ||||||||
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277.15 K / Instrument: FEI VITROBOT MARK IV | ||||||||
Details | SEC-purified |
-
Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Number grids imaged: 1 / Number real images: 14309 / Average exposure time: 1.34 sec. / Average electron dose: 56.36 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | C2 aperture diameter: 50.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.4 µm / Nominal defocus min: 0.8 µm / Nominal magnification: 130000 |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
Initial model | Chain - Source name: AlphaFold / Chain - Initial model type: in silico model |
---|---|
Refinement | Space: REAL / Protocol: RIGID BODY FIT |
Output model | ![]() PDB-8qz6: |